Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality

This publication has 32 references indexed in Scilit:

• A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
  New England Journal of Medicine, 2001
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
  New England Journal of Medicine, 1999
• Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry
  European Heart Journal, 1999
• Primary Prevention of Sudden Cardiac Death in Heart Failure: Will the Solution Be Shocking?
  Journal of the American College of Cardiology, 1997
• Differences Between Primary Care Physicians and Cardiologists in Management of Congestive Heart Failure: Relation to Practice Guidelines
  Journal of the American College of Cardiology, 1997
• Non-invasive prognostic factors in chronic heart failure. One-year survival of 300 patients with a diagnosis of chronic heart failure due to ischemic heart disease or dilated cardiomyopathy
  International Journal of Cardiology, 1996
• Increased risk of progressive hemodynamic deterioration in advanced heart failure patients requiring permanent pacemakers
  American Heart Journal, 1993
• Female sex as an important determinant of lisinopril-induced cough
  The Lancet, 1992
• Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure
  New England Journal of Medicine, 1991
• Effects of Enalapril on Mortality in Severe Congestive Heart Failure
  New England Journal of Medicine, 1987